Severe COVID-19 is characterized by an inflammatory profile that involves initial immune evasion by downregulation of Type I Interferon pathways along with significant upregulation of IL-6, IL-8 and TNF-α in the lungs that coincides with increased NF-κB activity [57, 58]. Here, CXCL8 is linked to COVID-19.